Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers

Poly (ADP-ribose) polymerase (PARP) inhibitors and platinum-based chemotherapies have been found to be particularly effective in tumors that harbor deleterious germline or somatic mutations in the BRCA1 or BRCA2 genes, the products of which contribute to the conservative homologous recombination rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Watkins, Johnathan A, Irshad, Sheeba, Grigoriadis, Anita, Tutt, Andrew NJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053155/
https://www.ncbi.nlm.nih.gov/pubmed/25093514
http://dx.doi.org/10.1186/bcr3670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053155/
https://www.ncbi.nlm.nih.gov/pubmed/25093514
http://dx.doi.org/10.1186/bcr3670

Ejemplares similares